Tenet Healthcare Corp. (THC) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Tenet Healthcare’s revenue went from $21.1B in fiscal 2016 to $21.3B in fiscal 2025, growth of about 0.1% a year.
Net income in fiscal 2025 was $1.4B, a net margin of 6.6%; the best year in this period was 2024 with $3.2B.
Over the twelve months to September 30, 2026, revenue was $22.2B and net income $2.9B.
Free cash flow was $2.5B in fiscal 2025 and positive in 9 of the 10 years shown.
The diluted share count fell 9% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.2B | $21.3B | $20.7B | $20.6B | $19.2B | $19.5B | $17.6B | $18.5B | $18.3B | $20.6B | $21.1B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $5.4B | $3.5B | $6.0B | $2.5B | $2.3B | $2.9B | $2.0B | $1.5B | $1.6B | $1.1B | $1.2B |
| Net income | $2.9B | $1.4B | $3.2B | $611M | $411M | $914M | $399M | -$215M | $104M | -$704M | -$192M |
| EPS (diluted) | $34.47 | $15.49 | $32.70 | $5.71 | $3.79 | $8.42 | $3.75 | $-2.08 | $1.00 | $-7.00 | $-1.93 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +3.1% | +0.5% | +7.2% | −1.6% | +10.5% | −4.5% | +0.9% | −11.2% | −2.2% | +4.8% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.2B | $3.5B | $2.0B | $2.4B | $1.1B | $1.6B | $3.4B | $1.2B | $1.0B | $1.2B | $558M |
| Capital spending | -$910M | -$1.0B | -$931M | -$751M | -$762M | -$658M | -$540M | -$670M | -$617M | -$707M | -$875M |
| Free cash flow | $3.3B | $2.5B | $1.1B | $1.6B | $321M | $910M | $2.9B | $563M | $432M | $493M | -$317M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $1.8B | $1.4B | $672M | $200M | $250M | $0 | $0 | — | — | $0 | $0 |
| Stock-based pay | $129M | $104M | $67M | $66M | $56M | $56M | $44M | $42M | $46M | $59M | $68M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $2.9B | $3.0B | $1.2B | $858M | $2.4B | $2.4B | $262M | $411M | $611M | $716M |
| Debt | — | $14.5B | $14.4B | $16.3B | $16.5B | $16.9B | $17.1B | $16.0B | $15.9B | $15.2B | $15.5B |
| Equity | — | $4.2B | $4.2B | $1.6B | $1.1B | $1.0B | $28M | -$417M | -$119M | -$147M | $417M |
| Total assets | — | $29.7B | $28.9B | $28.3B | $27.2B | $27.6B | $27.1B | $23.4B | $22.4B | $23.4B | $24.7B |
| Shares (diluted) | 81M | 91M | 98M | 105M | 111M | 109M | 106M | 103M | 104M | 101M | 99M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 24.4% | 16.5% | 28.8% | 12.2% | 12.2% | 14.7% | 11.3% | 8.3% | 8.9% | 5.4% | 5.9% |
| Net margin | 13.1% | 6.6% | 15.5% | 3.0% | 2.1% | 4.7% | 2.3% | -1.2% | 0.6% | -3.4% | -0.9% |
| FCF margin | 15.0% | 11.9% | 5.4% | 7.9% | 1.7% | 4.7% | 16.2% | 3.0% | 2.4% | 2.4% | -1.5% |
| ROIC | — | 15.8% | 24.8% | 11.3% | 9.9% | 12.5% | 9.2% | 5.0% | 7.5% | 5.9% | 5.7% |
| ROE | — | 33.3% | 76.7% | 38.0% | 36.0% | 88.9% | 1425.0% | 51.6% | -87.4% | 478.9% | -46.0% |
Frequently asked questions
What is Tenet Healthcare’s annual revenue?
$21.3B in fiscal 2025 and $22.2B over the twelve months to September 30, 2026.
How much profit does Tenet Healthcare make?
Net income was $1.4B in fiscal 2025 (net margin 6.6%).
Is Tenet Healthcare’s revenue growing?
Yes: revenue rose 3.1% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.